Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

MINOCIN

MINOCYCLINE HYDROCHLORIDE

Standard Dose
EQ 50MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview MINOCIN is listed in Drugs@FDA under application 050445 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MINOCYCLINE HYDROCHLORIDE Form and strength SUSPENSION;ORAL - EQ 50MG BASE/5ML Sponsor BAUSCH Submission history Latest submission status date: 2025-03-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview MINOCIN is listed in Drugs@FDA under application 050445 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MINOCYCLINE HYDROCHLORIDE Form and strength SUSPENSION;ORAL - EQ 50MG BASE/5ML Sponsor BAUSCH Submission history Latest submission status date: 2025-03-31 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.